Sunday, June 2, 2024
ADVT 
Health

Condom that neutralises HIV virus gets clearance

Darpan News Desk Darpan, 22 Jul, 2014 07:29 AM
    Australian authorities have approved a condom developed in the country which contains a substance that destroys AIDS-causing HIV and other sexually transmitted viruses almost entirely, media reported Tuesday.
     
    The biotech firm Starpharma has developed an antiviral compound called VivaGel that, according to laboratory tests, can render inactive up to 99.9 percent of HIV, herpes and some other sexually transmitted viruses, according to the ABC channel.
     
    This antiviral coating has been incorporated in the lubricant of several condoms manufactured by Ansell and has now received Conformity Assessment Certification from Australia's Therapeutic Goods Administration (TGA).
     
    Starpharma's chief executive Jackie Fairley said the approval from the Australian regulatory body is a step towards commercial availability of the product, which is expected in a few months.
     
    Describing their new product, Fairley said that VivaGel has anti-viral and anti-bacterial properties that inactivate HIV by reducing the number of viral particles.
     
    "The more viral particles you're exposed to, that typically translates into a greater chance of infection," Fairley said, adding that while condoms are the best means of protection against sexually transmitted infections, they are not 100 percent effective.

    MORE Health ARTICLES

    Fatty food may lead to loss of smell

    Fatty food may lead to loss of smell
    Stuffing yourself regularly with pizza or hamburger or any other high-fat food can put you at the risk of losing sense of smell, research warns....

    Fatty food may lead to loss of smell

    Functional human platelets generated in lab

    Functional human platelets generated in lab
    The US scientists have developed a next-generation platelet bioreactor to generate fully functional human platelets in the lab...

    Functional human platelets generated in lab

    'Revolutionary' antibiotics to tackle TB

    'Revolutionary' antibiotics to tackle TB
    Why mycobacteria - a family that includes the microbe that causes tuberculosis (TB) - survive oxygen limitation has long been a mystery but not any more....

    'Revolutionary' antibiotics to tackle TB

    'Simulated' human heart created for better drug testing

    'Simulated' human heart created for better drug testing
    In pioneering research, a scientist has developed a 'simulated' human heart to test the effect of drugs on the heart without using human or animal trials....

    'Simulated' human heart created for better drug testing

    Avian influenza treatments identified

    Avian influenza treatments identified
    In a novel discovery, scientists have identified six potential therapeutics to treat the deadly H7N9 avian influenza...

    Avian influenza treatments identified

    Genes play key role in twins' language deficit

    Genes play key role in twins' language deficit
    Contrary to the popular tendency to attribute delays in early language acquisition of twins to mothers, researchers have found that genes play a significant role in...

    Genes play key role in twins' language deficit